AB SCIEX Tripple Quad 5500+ QTRAP Ready Systems

The Florida Department of Law Enforcement (FDLE) is pursuing a single-source procurement for four AB SCIEX Tripple Quad 5500+ QTRAP Ready Systems, specifically targeting replacement of existing SCIEX 3200QTRAP instrumentation at the Orlando and Tallahassee Regional Operations Centers. These enhanced high-performance triple quadruple LC-MS/MS mass spectrometers are designed for processing and analyzing forensic evidence in drug detection and identification. The procurement is statutorily mandated and requires a fifteen business day advertisement, with the opportunity posted on March 31, 2025, and a final receipt date for information set for April 22, 2025. The key objectives include maintaining consistency with existing forensic laboratory equipment and processes, and ensuring compatibility with FDLE's Laboratory Information Management System (LIMS). The procurement specifically requires vendor AB SCIEX LLC of Redwood City, CA, with justification centered on the instrument's unique capabilities of containing both a linear ion trap and triple quadruple in the same device, as well as the existing proficiency of FDLE forensic technologists with SCIEX instruments and software.

This single-source procurement does not appear to have specific set-aside designations or restrictions on responding organizations. The current incumbent and proposed vendor is AB SCIEX LLC, with no indication of competitive bidding or alternative vendor considerations. The existing infrastructure involves current SCIEX 3200QTRAP instrumentation that will be directly replaced by the new systems. The procurement has a defined budget of $2,000,000.00 for the four mass spectrometry systems, representing a significant investment in forensic laboratory technology. The procurement is specifically targeted to Leon County and will support forensic operations in the Orlando and Tallahassee Regional Operations Centers. Integration requirements include maintaining compatibility with the existing LIMS and ensuring seamless transition of forensic processing capabilities. The procurement represents a strategic technology refresh for FDLE's forensic analysis capabilities, focusing on maintaining operational continuity and technological effectiveness in drug detection and identification processes.